Loading the company…
Loading the company…
In 2025, Cardiofocus reported engagement with 20 surgeons and other clinicians in the states MedaRep covers, worth $156K in consulting, speaking, meals and travel for its device products, the most in Oklahoma ($70K to 1). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Oklahoma ($70K, 1 engaged), Illinois ($23K, 4 engaged), Ohio ($18K, 1 engaged), California ($14K, 3 engaged), New York ($13K, 4 engaged).
In the last ten years FDA made 15 decisions for Cardiofocus (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2020 (4). The latest was on 2023-08-11.
| Family | Decisions on record |
|---|---|
| EP ablation | 16 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2023-08-11 | PMA | P150026-S015 | HeartLight Catheter, HeartLight X3 Console V2 · Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2023-02-24 | PMA | P150026-S014 | HeartLight Catheter, HeartLight X3 Console V2 · Change Design/Components/Specifications/Material |
| 2022-04-02 | PMA | P150026-S013 | HeartLight® X3 Catheter with Excalibur Balloon · Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2021-04-06 | PMA | P150026-S012 |
| HeartLight X3 Endoscopic Ablation System · Change Design/Components/Specifications/Material |
| 2020-07-01 | PMA | P150026-S011 | HeartLight Catheter and HeartLight Console · Postapproval Study Protocol |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Cardiofocus.